• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Psychosocial and Behavioral Outcomes for Persons With Cognitive Impairment and Caregivers Following Amyloid-β PET Scan Disclosure: A Systematic Review.认知障碍患者和照护者接受淀粉样蛋白 PET 扫描结果披露后的心理社会和行为结果:系统评价。
Alzheimer Dis Assoc Disord. 2023;37(3):246-258. doi: 10.1097/WAD.0000000000000569. Epub 2023 Jul 24.
2
How Accurately Do Patients and Their Care Partners Report Results of Amyloid-β PET Scans for Alzheimer's Disease Assessment?患者及其护理伙伴对阿尔茨海默病评估的淀粉样蛋白-β PET 扫描结果报告的准确性如何?
J Alzheimers Dis. 2020;74(2):625-636. doi: 10.3233/JAD-190922.
3
Amyloid-β PET Scan Results Disclosure and Care-Partner Emotional Well-Being Over Time.淀粉样蛋白-β PET 扫描结果披露与照护者情感健康随时间的变化。
J Alzheimers Dis. 2022;90(2):775-782. doi: 10.3233/JAD-220611.
4
Regional dynamics of amyloid-β deposition in healthy elderly, mild cognitive impairment and Alzheimer's disease: a voxelwise PiB-PET longitudinal study.健康老年人、轻度认知障碍和阿尔茨海默病患者中淀粉样-β沉积的区域动力学:基于 PiB-PET 的纵向研究。
Brain. 2012 Jul;135(Pt 7):2126-39. doi: 10.1093/brain/aws125. Epub 2012 May 23.
5
"I know that my role is going to change": a mixed-methods study of the relationship between amyloid-β PET scan results and caregiver burden.“我知道我的角色将会改变”:一项关于淀粉样蛋白-β PET 扫描结果与照料者负担之间关系的混合方法研究。
Aging Clin Exp Res. 2023 Feb;35(2):387-397. doi: 10.1007/s40520-022-02314-6. Epub 2022 Dec 9.
6
18F PET with flutemetamol for the early diagnosis of Alzheimer's disease dementia and other dementias in people with mild cognitive impairment (MCI).使用氟代甲磺酸去甲肾上腺素的18F正电子发射断层显像用于轻度认知障碍(MCI)患者中阿尔茨海默病性痴呆及其他痴呆的早期诊断。
Cochrane Database Syst Rev. 2017 Nov 22;11(11):CD012884. doi: 10.1002/14651858.CD012884.
7
Prevalence Estimates of Amyloid Abnormality Across the Alzheimer Disease Clinical Spectrum.阿尔茨海默病临床谱系中淀粉样蛋白异常的患病率估计
JAMA Neurol. 2022 Mar 1;79(3):228-243. doi: 10.1001/jamaneurol.2021.5216.
8
Elevated Amyloid-β PET Scan and Cognitive and Functional Decline in Mild Cognitive Impairment and Dementia of Uncertain Etiology.淀粉样蛋白-β PET 扫描与轻度认知障碍和病因不明的痴呆认知和功能下降。
J Alzheimers Dis. 2024;97(3):1161-1171. doi: 10.3233/JAD-230950.
9
Advance directives among cognitively impaired persons who had an amyloid PET scan and their care partners: a mixed-methods study.认知障碍且进行过淀粉样 PET 扫描的患者及其照护者的预先指示:一项混合方法研究。
BMC Palliat Care. 2022 Nov 6;21(1):194. doi: 10.1186/s12904-022-01082-4.
10
Testing and disclosures related to amyloid imaging and Alzheimer's disease: Common questions and fact sheet summary.与淀粉样蛋白成像和阿尔茨海默病相关的检测和披露:常见问题和情况说明书摘要。
Alzheimers Dement. 2016 Apr;12(4):510-5. doi: 10.1016/j.jalz.2016.03.002.

引用本文的文献

1
Communicating the risk of dementia: a scoping review.痴呆症风险的沟通:一项范围综述
BMJ Neurol Open. 2025 Jul 22;7(2):e001138. doi: 10.1136/bmjno-2025-001138. eCollection 2025.
2
Return of research results across the Alzheimer's Disease Research Centers network.阿尔茨海默病研究中心网络的研究结果反馈
Alzheimers Dement. 2025 Jun;21(6):e70418. doi: 10.1002/alz.70418.
3
Emotional distress following amyloid PET result disclosure: Heightened among those with cognitive symptoms.淀粉样蛋白PET结果披露后的情绪困扰:认知症状患者中更为严重。
Alzheimers Dement. 2025 Apr;21(4):e70121. doi: 10.1002/alz.70121.
4
Counseling and disclosure practices in predictive Alzheimer's disease diagnostics: A scoping review.预测性阿尔茨海默病诊断中的咨询与信息披露实践:一项范围综述
Alzheimers Dement. 2024 Dec;20(12):8910-8936. doi: 10.1002/alz.14365. Epub 2024 Nov 19.
5
Alzheimer Disease as a Clinical-Biological Construct-An International Working Group Recommendation.作为一种临床生物学概念的阿尔茨海默病——国际工作组建议
JAMA Neurol. 2024 Dec 1;81(12):1304-1311. doi: 10.1001/jamaneurol.2024.3770.
6
Psychological outcomes of dementia risk estimation in MCI patients: Results from the PreDADQoL project.痴呆风险评估对 MCI 患者心理结局的影响:PreDADQoL 项目的研究结果。
Alzheimers Dement. 2024 Nov;20(11):7635-7656. doi: 10.1002/alz.14226. Epub 2024 Oct 1.
7
"There has to be more caring": patient and care partner experiences of the disclosure of amyloid-β PET scan results.“必须要有更多关怀”:患者及护理伙伴对淀粉样蛋白β正电子发射断层扫描结果披露的体验
Aging Ment Health. 2025 Jan;29(1):112-120. doi: 10.1080/13607863.2024.2371471. Epub 2024 Jun 26.
8
Persons With Cognitive Impairment and Care Partner Motivations and Experiences of Undergoing an Amyloid Scan: A Systematic Review of Qualitative Studies.认知障碍患者及其照顾者接受淀粉样蛋白扫描的动机和体验:系统评价定性研究。
Gerontologist. 2024 Aug 1;64(8). doi: 10.1093/geront/gnae075.

认知障碍患者和照护者接受淀粉样蛋白 PET 扫描结果披露后的心理社会和行为结果:系统评价。

Psychosocial and Behavioral Outcomes for Persons With Cognitive Impairment and Caregivers Following Amyloid-β PET Scan Disclosure: A Systematic Review.

机构信息

Center for Gerontology and Health Care Research, Brown University School of Public Health, Providence, RI.

VA Advanced Imaging Research Center, San Francisco Veterans Administration Medical Center, San Francisco, CA.

出版信息

Alzheimer Dis Assoc Disord. 2023;37(3):246-258. doi: 10.1097/WAD.0000000000000569. Epub 2023 Jul 24.

DOI:10.1097/WAD.0000000000000569
PMID:37561950
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10529389/
Abstract

BACKGROUND

Positron emission tomography (PET) scans for amyloid-β can aid in the early and accurate detection of Alzheimer disease. The results of amyloid PET scans could help people with cognitive impairment and caregivers better understand their diagnosis; however, there are concerns that they could also cause psychological harm.

METHODS

A systematic review of psychosocial and behavioral quantitative outcomes following the disclosure of an amyloid PET scan for persons living with cognitive impairment (subjective cognitive decline, mild cognitive impairment, Alzheimer's Disease, and other dementias) and caregivers.

FINDINGS

Ten papers were identified from 7 studies. There was little evidence of an association between disclosure and depression. However, persons with mild cognitive impairment and their caregivers with elevated levels of amyloid had an increased risk of distress or anxiety compared with those without elevated amyloid. Participants correctly recalled the scan results; however, it is unclear whether this led to an increased understanding of their diagnosis. We did not identify any studies measuring behavioral outcomes.

CONCLUSIONS

We found mixed evidence on the relationship between amyloid scans and psychosocial and behavioral outcomes in people with cognitive impairment and caregivers. These findings highlight the need for more methodologically rigorous research on this topic.

摘要

背景

正电子发射断层扫描(PET)可用于检测淀粉样蛋白-β,有助于早期、准确地发现阿尔茨海默病。淀粉样蛋白 PET 扫描的结果可以帮助认知障碍患者及其护理人员更好地了解其诊断;然而,人们担心它也可能会造成心理伤害。

方法

对有认知障碍(主观认知下降、轻度认知障碍、阿尔茨海默病和其他痴呆症)的患者及其护理人员进行淀粉样蛋白 PET 扫描后,对其进行心理社会和行为学定量结果的系统评价。

发现

从 7 项研究中确定了 10 篇论文。有证据表明披露结果与抑郁之间没有关联。然而,与没有淀粉样蛋白升高的人相比,轻度认知障碍患者及其有淀粉样蛋白升高的护理人员有更高的焦虑或抑郁风险。参与者正确地回忆了扫描结果;然而,目前尚不清楚这是否增加了他们对诊断的理解。我们没有发现任何衡量行为结果的研究。

结论

我们发现,淀粉样蛋白扫描与认知障碍患者及其护理人员的心理社会和行为结果之间的关系存在混合证据。这些发现强调了需要在这一主题上开展更多具有严格方法学的研究。